“The expeditious diagnosis and treatment of infantile spasms is essential. To the extent that ongoing infantile spasms and hypsarrhythmia pose a significant threat to long‐term development, the greatest harm is believed to be sustained early …”*
Because infantile spasms can be catastrophic to development, resection or disconnection surgery should be considered as soon as possible for children with focal, including unilateral or unihemispheric, brain malformations.
If your child has failed frontline medical treatments (vigabatrin (Sabril) and adrenocorticotropphic hormone (ACTH) or prednisolone) – do not delay! It is time for a surgical evaluation.
Referral for a surgical evaluation should occur when:
Your child has failed first-line treatments
No longer considered a last resort, epilepsy surgery is a viable treatment option to stop seizures when the child’s infantile spasms are considered drug-resistant (also known as intractable or refractory).
The most recent practice guidelines from the American Academy of Neurology and the Child Neurology Society for the medical treatment of infantile spasms state that adrenocorticotropic hormone (ACTH, sold as Acthar gel) and Vigabatrin (also sold as Sabril) are the first line drugs for infantile spasms. There is also some evidence that high-dose oral prednisolone can be an effective treatment as well.
If a child has failed these drug combinations, the infantile spasms are considered drug resistant. To understand the meaning of drug resistance, we explain it in detail here.
One third of children presenting with infantile spasms before 36 months of age will be drug-resistant – and the largest group are children with infantile spasms. Children with focal or hemispheric lesions or malformations, such as hemimegalencephaly and cortical dysplasia (the children most often considered for surgery) also carry a high risk of drug resistance.
Your child has a focal cortical abnormality
The International League Against Epilepsy recommends a surgical evaluation for that infants with drug resistant epilepsy who have focal-onset seizures – particularly those with a unilateral structural brain abnormality such as hemimegalencephaly, or focal cortical abnormalities such as the cortical dysplasias, tuberous sclerosis, and porencephaly. A presurgical evaluation will attempt to map the cortical abnormality so that the surgeon knows what part of the brain to remove.
If the child does not have a focal abnormality, corpus callosotomy is also an option. In a recent research study of 56 children who had corpus callosotomy to stop infantile spasms, almost 43% were free of infantile spasms after surgery.
Your child does not have a metabolic or degenerative brain condition
Children with degenerative brain conditions or metabolic disorders which cause seizures typically are not candidates for resective epilepsy surgery.
Your child exhibits delay or developmental arrest
In order to be a candidate for surgery, your child must be progressing very slowly or development has “frozen in time”. Most children with drug-resistant infantile spasms exhibit significant developmental delay or development arrest.
There is no unacceptable loss of function if surgery is selected
Very difficult decisions must be made – and fast – for parents considering brain surgery to stop their child’s infantile spasms. The most sobering decision to make is how much function are you willing to lose in exchange for stopping the infantile spams? When considering surgery, remember that ongoing infantile spasms will cause serious developmental regression or arrest and, in many cases, death.
The sooner the better
Research shows that surgery should be considered as soon as possible rather than waiting months or years. This is because seizures, especially in infancy, can be catastrophic – this means that they are strongly associated with intellectual disability(formerly known as mental retardation) and poor developmental outcome.
Infantile spasms are associated with an almost four-point IQ drop for every week they continue.
If your child has uncontrolled infantile spasms, you are already aware that your child will probably always face physical, developmental, and/or behavioral challenges regardless of the treatments that you choose. Moderate or severe learning difficulties may be present in 70–90% of children with infantile spasms. Autism is present in up to 30% of children with epilepsy, especially in children who had seizures in the first two years of life. Sadly, the premature death rate is reported between 5 – 33% in children with infantile spasms.
It is unlikely that your child will “grow out” of infantile spasms
You may be wondering if you should wait and see if your child’s infantile spasms go away on their own. It is true that the spasm seizure type stops by three years of age in approximately one-half of children with infantile spasms and rarely continues after age five; however, 50 to 90 percent of patients with infantile spasms will go on to develop other seizure types. In general, patients with infantile spasms caused by stroke, brain malformations, or other known cause more likely to develop other seizure types than those with infantile spasms with no known cause (57.5 versus 35.3). Approximately 27 to 50 percent of patients with infantile spasms develop a severe form of epilepsy known as Lennox-Gastaut syndrome.
Reading about the long-term consequences of infantile spasms is disheartening for any parent. However, patients with infantile spasms who are also epilepsy surgery candidates are offered a unique opportunity to permanently stop or reduce spasms and future seizure types and lower the number of anti-epileptic medications that they need to take. Seizure and medication reduction can lead to improved development and behavior that can change your child’s and your family’s quality of life for the better.